New Zealand markets closed

Belite Bio, Inc (BLTE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
42.05-0.45 (-1.06%)
At close: 04:00PM EDT
42.05 -0.46 (-1.08%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.25B
Enterprise value 1.16B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)13.84
Enterprise value/revenue N/A
Enterprise value/EBITDA -85.58

Trading information

Stock price history

Beta (5Y monthly) -1.53
52-week change 378.94%
S&P500 52-week change 326.27%
52-week high 348.60
52-week low 311.00
50-day moving average 340.62
200-day moving average 338.25

Share statistics

Avg vol (3-month) 340.43k
Avg vol (10-day) 331.75k
Shares outstanding 529.75M
Implied shares outstanding 630.07M
Float 811.21M
% held by insiders 159.01%
% held by institutions 10.74%
Shares short (30 Apr 2024) 418.85k
Short ratio (30 Apr 2024) 40.68
Short % of float (30 Apr 2024) 40.16%
Short % of shares outstanding (30 Apr 2024) 40.06%
Shares short (prior month 28 Mar 2024) 439.12k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-28.50%
Return on equity (ttm)-47.95%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -31.53M
Net income avi to common (ttm)-31.63M
Diluted EPS (ttm)-1.19
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.16M
Total cash per share (mrq)3.02
Total debt (mrq)886k
Total debt/equity (mrq)0.98%
Current ratio (mrq)24.76
Book value per share (mrq)3.10

Cash flow statement

Operating cash flow (ttm)-29.84M
Levered free cash flow (ttm)-15.3M